Reduced serum nerve growth factor in patients with late-life depression

American Journal of Geriatric Psychiatry

Volumn 21, Issue 5, 2013, Pages 493-496

  Diniz, Breno S ^a,b   Teixeira, Antonio L ^a   Machado Vieira, Rodrigo ^b   Talib, Leda L ^b   Gattaz, Wagner F ^b   Forlenza, Orestes V ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Latelife depression; Nerve growth factor; Neurotrophins; Physiopathology; State marker

Indexed keywords

NERVE GROWTH FACTOR;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LATE LIFE DEPRESSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL;

AGED; AGING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; REMISSION INDUCTION;

EID: 84880169098     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.01.014     Document Type: Article

References (15)

1. Chao MV: Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003; 4: 299-309 (Pubitemid 37271375)
2. Teixeira AL, Barbosa IG, Diniz BS, et al: Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med 2010; 4: 871-887
3. Hellweg R, von Richthofen S, Anders D, et al: The time course of nerve growth factor content in different neuropsychiatric diseases-a unifying hypothesis. J Neural Transm 1998; 105: 871-903 (Pubitemid 28539835)
4. Nockher WA, Renz H: Neurotrophins and asthma: novel insight into neuroimmune interaction. J Allergy Clin Immunol 2006; 117: 67-71 (Pubitemid 43017141)
5. Ziegenhorn AA, Schulte-Herbräggen O, Danker-Hopfe H, et al: Serum neurotrophins-a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 2007; 28:1436-1445 (Pubitemid 47090171)
6. First MB, Spitzer RL, Gibbon M: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York, NY, Biometrics Research, New York State Psychiatric Institute; 2002
7. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
8. Roth M, Tym E, Mountjoy CQ, et al: CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149:698-709 (Pubitemid 17205276)
9. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
10. Pan W, Banks WA, Kastin AJ: Permeability of the blood-brain barrier to neurotrophins. Brain Res 1998; 788:87-94 (Pubitemid 28202147)
11. Diniz BS, Teixeira AL, Talib L, et al: Interleukin-1 beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry 2010; 18:172-176
12. Hellweg R, Ziegenhorn A, Heuser I, et al: Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry 2008; 41:66-71 (Pubitemid 351427525)
13. Duman RS, Monteggia LM: A neurotrophic model for stressrelated mood disorders. Biol Psychiatry 2006; 59:1116-1127
14. Cattaneo A, Sesta A, Calabrese F, et al: The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology 2010; 35:1423-1428
15. Price RD, Milne SA, Sharkey J, et al: Advances in small molecules promoting neurotrophic function. Pharmacol Ther 2007; 115:292-306 (Pubitemid 47042910) Silva